Read + Share
Amedeo Smart
Independent Medical Education
Parghane RV, Talole S, Basu S. (131)I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with (177)Lu-DOTATATE peptide receptor radionuclide therapy. Ann Nucl Med 2021;35:92-101.PMID: 33135123
Email
LinkedIn
Facebook
Twitter
Privacy Policy